The Pharmaceutical Market: South Africa Opportunities and Challenges

Publisher Name :
Date: 8-Nov-2012
No. of pages: 103

OVERVIEW OF THE PHARMACEUTICAL MARKET IN SOUTH AFRICA

The government drive to support local production and reduce the country’s reliance on imports, in addition to global epidemiological and demographic trends, are all positive factors contributing to long-term growth in the pharmaceutical market. However, deep segregation between private and public healthcare facilities continues to leave the vast majority of the population without medical care. BMI believes this will be rectified through the creation of the National Health Insurance scheme over the next decade, but in the meantime unemployment, lack of education and geographical inaccessibility to healthcare for the wider population will continue to hinder growth in the market.

Headline Expenditure Projections Pharmaceuticals: ZAR27.19bn (US$3.74bn) in 2011 to ZAR29.61bn (US$3.61bn) in 2012; +8.9% in local currency and -3.5% in US dollar terms. Healthcare: ZAR261.51bn (US$36.01bn) in 2011 to ZAR285.26bn (US$34.79bn) in 2012; +9.1% in local currency terms and -3.4% in US dollar terms. Medical devices: ZAR11.43bn (US$1.57bn) in 2011 to ZAR12.19bn (US$1.49bn) in 2012; +6.7% in local currency terms and -5.5% in US dollar terms. Forecast changed due to depreciation of the South African rand.

Product Description

The South Africa Pharmaceuticals & Healthcare Report features Espicom’s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

Espicom’s South Africa Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the South Africa pharmaceutical and healthcare industry.

Key Benefits

  • Benchmark Espicom’s independent pharmaceutical and healthcare industry forecasts to test other views – a key input for successful budgeting and strategic business planning in the South Africa pharmaceutical and healthcare market.
  • Target business opportunities and risks in the pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in South Africa.
  • Assess the activities, strategy and market position of your competitors, partners and clients via our Company Profiles (inc. SWOTs, KPIs and latest activity) and Competitive Landscape Tables.

Executive Summary & Industry SWOT

An at-a-glance perspective on latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The SWOT outlines strategic factors which affect Espicom’s forecast analysis, and taken together with Espicom’s political, economic and business environment SWOTS, it gives a complete overview of market climate.

Market Summary
Snapshot of key market characteristics, including total size of pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape.

Regulatory Regime
Details of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation and advertising, as well as an analysis of the overall regulatory burden.

Industry Developments
Focus on government healthcare reforms, epidemiological trends, company M&As, product launches, market entries, FDI activity, R&D, biotechnology, clinical trials and supply chain issues.

Espicom Industry Forecasts
Forecasts to end-2016 for all key industry indicators (see list below) supported by explicit assumptions, plus analysis of key downside risks to the main forecast, including:

  • Healthcare: Total healthcare expenditure (US$bn), healthcare expenditure (% of GDP), healthcare expenditure per capita (US$), hospital beds (per `000 population), doctors (per `000 population), birth and mortality rate (per `000 population)
  • Pharmaceutical market: Drug expenditure (US$bn), drug expenditure (% of GDP), drug expenditure per capita (US$)
  • Patented drug market: Prescription drug sales (US$bn), prescription sales (% of total sales), sales broken down by 14 therapeutic areas (cardiovascular, anti-infectives etc.)
  • Generic drug market: Generic product sales (US$bn), generic sales (% of total sales)
  • OTC drug market: OTC sales (US$bn), OTC sales (% of total sales), sales broken down by product types (analgesics, skin treatments, vitamins and minerals etc.)
  • Medical Devices: Medical device sales (US$bn), medical device sales (% of total healthcare market)
  • Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against US$, government expenditure, external debt.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales – for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Company Profiles

Examines the competitive positioning and short- to medium-term business strategies of key industry players. Strategy is examined within the context of Espicom’s industry forecasts, our macroeconomic views and our understanding of the wider competitive landscape to generate Company SWOT analyses. The latest financial and operating statistics and key company developments are also incorporated within the company profiles, enabling a full evaluation of recent company performance and future growth prospects.

The Pharmaceutical Market: South Africa Opportunities and Challenges

EXECUTIVE SUMMARY... 1
Snapshot: Strategic Espicom Analysis.........2
Snapshot: Key Data Projections......3

MACROENVIRONMENT . 4

POLITICAL.....4

ECONOMIC...5
Projections...........5

LEGAL............6

DEMOGRAPHIC........7
Projections...........7
Latest Figures.......8
Demographic Indicators..9
Birth Rate... 9
Death Rate. 9
Infant MortalityRate (IMR) 9
Life Expectancy at Birth.... 9

EPIDEMIOLOGY............ 10

DISEASE BURDEN...10

DISEASE PREVALENCE........11
Communicable Diseases11
HIV/AIDS... 11
Malaria...... 11
TB.. 12
Non-Communicable Diseases....12
Cancer....... 12

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS.. 13

ORGANISATION......13
National Health Insurance..........13

EXPENDITURE.........14
Projections.........14
Latest Figures.....15

INFRASTRUCTURE..16
Hospital Infrastructure..16
Netcare Group ..... 17
Hospital Bed Provision...17

WORKFORCE...........18
Projections.........18
Physicians...........19
Public Workforce............19

REGULATORY AFFAIRS 20

NATIONAL AUTHORITY..... 20

MARKETING REGISTRATION.......... 20
National Procedures.......20

TRADE REGULATIONS ........21
Parallel Trade.....21

PRICING & REIMBURSEMENT... 22

NATIONAL AUTHORITY..... 22

PRICING...... 22
Dispensing Fees Charged by Pharmacists..........22

REIMBURSEMENT . 23
Essential Drugs List........23

DISTRIBUTION CHANNELS....... 24

DRUG RETAILING....24
Public Pharmacies............24
Private Pharmacies..........24
Pharmacy Trade Association......25
USAP.........25
Leading Pharmacy Chains..........25
Clicks.........25
Dischem...25
Medipost Courier Pharmacy.......25

MARKET ANALYSIS....... 26

SIZE 26
Projections.........26
Historical Figures............28
Current Structure............29
ARV Tender...........30

PRODUCT DEVELOPMENT 30

MANUFACTURING. 30

TRADE.........31
Exports..31
Imports..33
Balance of Trade38

COMPETITION.. 39

TRADE ASSOCIATION..........39

PIASA........39

COMPANY INTELLIGENCE. 40
Adcock Ingram.....40
Aspen Pharmacare...........40
Merck South Africa........... 41
Competitive Strategies..41
OTC PHARMACEUTICALS.......... 43

MARKET SIZE...........43

COMPETITION.........43
Trade Association...........43
SMASA......43

GENERIC PHARMACEUTICALS 44

MARKET SIZE.......... 44

COMPETITION........ 44
Trade Association...........44
NAPM........44
Company Intelligence....45
Aspen Pharmacare...........45
Cipla Medpro........45
Ranbaxy...45

BIOLOGICS & BIOSIMILARS......46

PRODUCT DEVELOPMENT 46
Lifelab.......46
TIA46

COMPETITION........ 46
Trade Association...........46
IMSA..........46
Company Intelligence....47
Arvir Technologies........... 47
Bioclones.. 47
Elevation Biotech. 47
iThemba Pharmaceuticals........... 47
Key Oncologics..... 47
National Bioproducts Institute... 47

CONCLUSIONS: OPPORTUNITIES & CHALLENGES.........48
Strategic Espicom Analysis............ 48
MACROENVIRONMENT...48
EPIDEMIOLOGY..48
HEALTHCARE......48
REGULATORY AFFAIRS....49
PRICING & REIMBURSEMENT......49
DISTRIBUTION CHANNELS..........50
MARKET.50
COMPETITION ....51
OTC PHARMACEUTICALS51
GENERIC PHARMACEUTICALS.....51
BIOLOGICS & BIOSIMILARS.........51
Radar Analysis........53
SWOT Analysis........53

DIRECTORY...... 54

COMPETITION........ 54
Pharmaceutical Companies........54
Generic Companies........54
Biologic Companies........54

GOVERNMENT ORGANISATIONS.. 54

PRODUCT DEVELOPMENT 54

TRADE ORGANISATIONS... 54

List of Tables
Espicom Analysis of the Pharmaceutical Market, 2012.. 2
Key Data Projections, 2011-2016.......... 3
Political Landscape, 2012........ 4
Regional Ranking of Projected Economies, 2016........... 5
Projected Economy, 2011-2016............ 5
Regional Ranking of Projected Demographics, 2016..... 7
Projected Demographics, 2011-2016... 7
Population by Gender & Province, 2011............ 8
Population by Gender & Age, 2011...... 8
Births, Deaths & Natural Increase, 1997-2010.. 9
Selected Causes of Death by Sex, 2007-2009.. 10
Estimated Number of Adults & Children Receiving ART, 2005-2010.......11
Reported Cases of Selected Communicble Diseases, 1990-201012
Regional Ranking of Projected Health Expenditure, 2016........ 14
Projected Health Expenditure, 2011-2016....... 14
Health Funding by Sector, 2007/08-2009/10 (Rand Millions)...15
Public Sector Hospitals by Province, 2004-2011........... 16
Private Sector Hospitals by Province, 2004-2010......... 16
Public Sector Hospital Beds by Province, 2005-2009....17
Private Sector Hospital Beds by Province, 1998-2010...17
Regional Ranking of Projected Physicians, 2016.......... 18
Projected Physicians, 2011-2016........ 18
Physicians by Province, 2009-2011.... 19
Public Physicians, Nurses, Dentists & Pharmacists, 2000-2011 19
Regional Ranking of Projected Pharmaceutical Markets, 2016 26
Projected Pharmaceutical Market at Retail Prices, 2011-2016.. 28
Historical Pharmaceutical Market at Retail Prices, 1995-2010. 28
Pharmaceutical Retail Sales by Month at Current Prices, 2005-2011 (R Millions) 29
Pharmaceutical Exports by Category, 1995-2010 (US$000s).... 31
Pharmaceutical Exports by Country/Region, 2010 (US$000s).. 32
Pharmaceutical Imports by Category, 1995-2010 (US$000s)... 33
Imports of Raw Materials by Country/Region, 2010 (US$000s)............ 35
Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s).... 36
Imports of Medicaments by Country/Region, 2010 (US$000s) 37
Balance of Pharmaceutical Trade, 1995-2010 (US$000s)......... 38
Member Companies of PIASA, 2011... 39
Member Companies of SMASA, 2011. 43
Member Companies of NAPM, 2011..44
Member Companies of IMSA, 2011....46
Espicom Analysis of the Pharmaceutical Market, 2012 52
SWOT Analysis of the Pharmaceutical Market, 2012... 53

List of Charts
Regional Comparison of Projected Pharmaceutical Markets at Retail Prices, 2016 27
Regional Comparison of Projected Pharmaceutical Market Share, 2016........... 27
Historical Pharmaceutical Market at Retail Prices, 1995-2010. 29
Pharmaceutical Exports, 1995-2010 (US$ Millions) .... 31
Pharmaceutical Imports, 1995-2010 (US$ Millions).... 33
Pharmaceutical Imports by Country/Region, 2010 (%)............ 34
Balance of Pharmaceutical Trade, 1995-2010 (US$ Millions)... 38
Radar Graph of the Pharmaceutical Market, 2012...... 53

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Multinational Pharmaceuticals Companies in Asia Online Database
    Published: 20-Oct-2014        Price: US $1660 Onwards        
    The Multinational Pharmaceuticals Companies in Asia Online Database contains the latest available, individually researched data for 6690 senior executives at 2020 leading American, Asian, European and Middle Eastern & African multinational companies and key local companies in Asia. About the Multinational Pharmaceuticals Companies in Asia Online Database The Multinational Pharmaceuticals Companies in Asia Online Database is a powerful, cost-effective business development and research t......
  • EpiCast Report: Dyslipidemia – Epidemiology Forecast to 2023
    Published: 15-Oct-2014        Price: US $3995 Onwards        Pages: 94
    Dyslipidemia is a condition in which one or more of the serum lipid levels are abnormal. It is a well-established risk factor for cardiovascular disease, and the burden of morbidity, mortality, and medical costs arising from dyslipidemia is substantial. GlobalData epidemiologists forecast that the total prevalent cases of dyslipidemia in the 8MM will increase from 572,418,492 total prevalent cases in 2013, to 685,905,635 total prevalent cases in 2023, at an Annual Growth Rate (AGR) of 1.99%. ......
  • Global Proton Therapy Market 2014-2018
    Published: 15-Oct-2014        Price: US $2500 Onwards        Pages: 63
    Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy. The MD Anderson Proton Therapy Center is the pioneer in this technology an......
  • Pharmaceutical Business Confidence Report Q3 2014
    Published: 10-Oct-2014        Price: US $1950 Onwards        Pages: 60
    Summary "Pharmaceutical Business Confidence Report Q3 2014” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinion with regards to the current and future state of the economy and its retrospective effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, a......
  • 2014 Deep Research Report on Middle East and Africa Solid Organ Transplant Immunosuppressant Industry
    Published: 9-Oct-2014        Price: US $2200 Onwards        Pages: 120
    This is a professional and depth research report on Middle East and Africa Countries Solid Organ Transplant Immunosuppressant industry. The report firstly introduced Solid Organ Transplant Immunosuppressant basic information including Solid Organ Transplant Immunosuppressant definition classification application industry chain structure industry overview and Middle East and Africa countries market analysis, then statistics Middle East and Africa Countries key manufacturers Solid Organ Transplant......
  • United States – Pain Management Therapeutics Patients & Market Analysis
    Published: 8-Oct-2014        Price: US $1100 Onwards        Pages: 73
    Pain management is one of the fast growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The United States pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain. The pain management market is fuelled by the segments like arthritis pain, cancer pain, back pain, fibromyalgia, migraine pain, neuropathic pain and post–operative pain relief markets. T......
  • EpiCast Report: Allergic Conjunctivitis – Epidemiology Forecast to 2023
    Published: 7-Oct-2014        Price: US $3995 Onwards        Pages: 30
    Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In allergic conjunctivitis, the conjunctiva a layer of tissue which lines the front part of the eyeball (the white part of the eye) and the inside of the eyelids is inflamed secondary to an immune response to external antigens, usually called allergens. Allergic conjunctivitis is one of the most common eye prob......
  • Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014
    Published: 7-Oct-2014        Price: US $2500 Onwards        Pages: 129
    GlobalData's clinical trial report, "Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a prelimina......
  • Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 – New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
    Published: 1-Oct-2014        Price: US $4995 Onwards        
    GBI Research, the leading business intelligence provider, has released its latest research, ‘Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries’, which provides insights into Major Depressive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of market size for 2013, along with market fo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs